Valuation: Highnoon Laboratories Limited

Market Cap 51.78B 187M 160M 149M 137M 257M 17.89B 263M 1.76B 690M 8.98B 701M 686M 29.73B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 51.78B 187M 160M 149M 137M 257M 17.89B 263M 1.76B 690M 8.98B 701M 686M 29.73B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.52x
Free-Float
50.02%
Yield 2026 *
4.6%
Yield 2027 * 5.32%
1 day-0.59%
1 week-1.77%
Current month-0.63%
1 month-0.29%
3 months+3.85%
6 months-1.78%
Current year-4.42%
1 week 975
Extreme 975
1,010
1 month 954.5
Extreme 954.5
1,057
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,241
3 years 330
Extreme 330
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.855793
1,241
Manager TitleAgeSince
Chief Executive Officer - 2015-03-31
Chief Executive Officer 63 1995-12-31
Director of Finance/CFO - 2020-03-31
Director TitleAgeSince
Chairman - 2012-09-06
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.59%-1.77%-18.53%+156.33% 188M
-2.81%+1.98%+76.96%+127.73% 1,141B
-2.21%+2.50%+50.38%+55.01% 659B
-1.56%+5.25%+26.98%+74.39% 470B
+1.20%+1.72%+42.89%+45.78% 366B
-0.61%+1.72%+25.21%+41.34% 302B
+0.32%+3.30%+2.60%+13.42% 254B
-1.95%+4.22%+46.75%+65.66% 239B
-1.10%-1.12%-14.91%-52.66% 207B
-2.82%+5.57%+21.58%+89.04% 183B
Average -0.54%+3.43%+25.99%+61.60% 382.12B
Weighted average by Cap. -0.06%+4.31%+44.42%+70.86%

Financials

2026 *2027 *
Net sales 30.4B 110M 93.84M 87.76M 80.4M 151M 10.5B 154M 1.03B 405M 5.27B 412M 403M 17.46B 34.16B 123M 105M 98.63M 90.36M 170M 11.8B 173M 1.16B 455M 5.92B 463M 453M 19.62B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
26-08-20 PKR 977.30 -0.59% 60,307
26-08-19 PKR 983.09 -0.63% 13,575
26-08-18 PKR 989.29 -0.52% 20,988
26-08-17 PKR 994.49 -0.90% 9,554
26-08-13 PKR 1,003.54 +0.86% 5,359
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
977.30PKR
Average target price
1,121.00PKR
Spread / Average Target
+14.70%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock